BioNTech SE BNTX:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/01/21 EST
110.10quote price arrow down-0.11 (-0.10%)
Volume
7,627
Close
110.21quote price arrow up+1.18 (+1.08%)
Volume
866,637
52 week range
28.00 - 131.00

...

Loading . . .

KEY STATS

  • Open110.00
  • Day High111.45
  • Day Low108.06
  • Prev Close110.21
  • 52 Week High131.00
  • 52 Week High Date12/11/20
  • 52 Week Low28.00
  • 52 Week Low Date03/12/20
  • Market Cap26,537.46M
  • Shares Out240.79M
  • 10 Day Average Volume1.41M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change213.99

RATIOS/PROFITABILITY

  • EPS (TTM)-2.01
  • P/E (TTM)-54.92
  • Fwd P/E (NTM)11.62
  • EBITDA (MRQ)-103.17M
  • ROE (MRQ)-
  • Revenue (MRQ)161.56M
  • Gross Margin (MRQ)88.28%
  • Net Margin (MRQ)-85.07%
  • Debt To Equity (MRQ)33.50%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

QUOTE FINDER

Profile

MORE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company...
Address
An der Goldgrube 12
Mainz
55131
Germany